Ryan concentrates on complex intellectual property litigation. His patent litigation work has been recognized by The Legal 500, among others. He has represented clients in the pharmaceutical, biotech, consumer products, telecommunications and high-tech sectors in District Courts, the Federal Circuit Court of Appeals and the Patent Trial and Appeal Board (PTAB). He also routinely advises innovative companies on the patent-related aspects of acquisitions, licenses and other transactions.
Ryan has extensive experience representing and counseling clients in the pharmaceutical industry, including at trial in their most important patent cases. He has litigated numerous cases arising under the Hatch-Waxman Act. His clients include leading biopharmaceutical companies like Pfizer, Novo Nordisk and UCB, as well as emerging companies striving to protect their IP and find a path to market. Through his many years of experience with the industry, Ryan understands the numerous regulatory, commercial and scientific challenges that these companies face, and this knowledge informs all facets of his representations. Beyond patent litigation, Ryan also has substantial experience representing pharmaceutical companies in antitrust matters and other complex commercial litigation.
Before attending law school, Ryan researched experimental recombinant DNA vaccines for the HIV virus. He also spent several years working for a leading consumer products company as a product formulator and process development engineer.
Prior to joining Fenwick, Ryan was a partner in the litigation group at a leading international law firm.